JPMorgan Chase & Co’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $731K | Buy |
|
|||||
|
2025
Q1 | $330K | Sell |
|
|||||
|
2024
Q4 | $2.41M | Buy |
|
|||||
|
2024
Q3 | $487K | Buy |
|
|||||
|
2024
Q2 | $406K | Buy |
|
|||||
|
2024
Q1 | $332K | Sell |
|
|||||
|
2023
Q4 | $257K | Buy |
|
|||||
|
2023
Q3 | $220K | Buy |
|
|||||
|
2023
Q2 | $223K | Sell |
|
|||||
|
2023
Q1 | $228K | Buy |
|
|||||
|
2022
Q4 | $205K | Sell |
|
|||||
|
2022
Q3 | $256K | Buy |
|
|||||
|
2022
Q2 | $231K | Sell |
|
|||||
|
2022
Q1 | $253K | Buy |
|
|||||
|
2021
Q4 | $309K | Buy |
|
|||||
|
2021
Q3 | $341K | Buy |
|
|||||
|
2021
Q2 | $209K | Sell |
|
|||||
|
2021
Q1 | $1.59M | Buy |
|